National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Pheochromocytoma Treatment (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 01/03/2008



Purpose of This PDQ Summary






General Information






Cellular Classification






Stage Information






Treatment Option Overview






Localized Benign Pheochromocytoma






Regional Pheochromocytoma






Metastatic Pheochromocytoma






Recurrent Pheochromocytoma






Get More Information From NCI






Changes to This Summary (01/03/2008)






More Information



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Cellular Classification

Histologically, pheochromocytoma is composed of large pleomorphic chromaffin cells. Electron microscopy reveals electron-dense neurosecretory granules. Approximately 10% of pheochromocytomas are considered to be malignant. No histologic features exist that distinguish benign from malignant tumors. Microscopic evidence for local invasion of tissue or blood vessels, however, suggests malignancy.[1] Criteria based on tumor size, mitotic index, and DNA ploidy have been reported to be helpful in some series, though they are not always reliable predictors of biologic behavior.[2-4] Because the distinction between benign and malignant tumors cannot be made with certainty, careful surveillance is needed for a prolonged period after the initial surgical resection.

References

  1. Manger WM, Gifford RW: Pheochromocytoma. New York: Springer-Verlag, 1977. 

  2. Amberson JB, Vaughan ED Jr, Gray GF, et al.: Flow cytometric determination of nuclear DNA content in benign adrenal pheochromocytomas. Urology 30 (2): 102-4, 1987.  [PUBMED Abstract]

  3. Hosaka Y, Rainwater LM, Grant CS, et al.: Pheochromocytoma: nuclear deoxyribonucleic acid patterns studied by flow cytometry. Surgery 100 (6): 1003-10, 1986.  [PUBMED Abstract]

  4. Capella C, Riva C, Cornaggia M, et al.: Histopathology, cytology and cytochemistry of pheochromocytomas and paragangliomas including chemodectomas. Pathol Res Pract 183 (2): 176-87, 1988.  [PUBMED Abstract]

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov